High prevalence of syringe lending among HIV-positive people who inject drugs in Bangkok, Thailand

Harm Reduction Journal

Thomas Kerr⁴  Evan Wood⁴  Paisan Suwannawong³  Karyn Kaplan³  Lianping Ti²  Kanna Hayashi¹  Pauline Voon² 

[1] Urban Health Research Initiative, British Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, 608 - 1081 Burrard Street, Vancouver V6Z 1Y6, BC, Canada;School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada;Thai AIDS Treatment Action Group, Bangkok, Thailand;Department of Medicine, University of British Columbia, St. Paul’s Hospital, Vancouver, BC, Canada

关键词: Antiretroviral;    Harm reduction;    Polysubstance use;    Thailand;    Bangkok;    Syringe sharing;    Syringe lending;    People who inject drugs;    Injection drug use;    HIV;   

Others  :  1211917
DOI  :  10.1186/s12954-015-0050-5

 received in 2015-02-18, accepted in 2015-05-18,  发布年份 2015

【 摘 要 】

Background

Syringe sharing continues to be a major driver of the HIV pandemic. In light of efforts to enhance access to sterile syringes and promote secondary prevention among HIV-positive individuals, we sought to identify the prevalence and correlates of used syringe lending among self-reported HIV-positive people who inject drugs (PWID) in Bangkok, Thailand.

Findings

We used bivariable statistics to examine factors associated with self-reported syringe lending among self-reported HIV-positive PWID participating in the Mitsampan Community Research Project, a serial cross-sectional study of PWID in Bangkok, between June 2009 and October 2011. In total, 127 individuals were eligible for this analysis, including 25 (19.7 %) women. Twenty-one (16.5 %) participants reported syringe lending in the prior 6 months. Factors significantly associated with syringe lending included daily methamphetamine injection (odds ratio (OR) = 10.2, 95 % CI, 2.1–53.6), daily midazolam injection (OR = 3.1, 95 % CI, 1.1–8.7), use of drugs in combination (OR = 4.5, 95 % CI, 1.0–41.6), injecting with others on a frequent basis (OR = 4.25, 95 % CI, 1.3–18.3), and not receiving antiretroviral therapy (OR = 2.9, 95 % CI, 1.1–7.9).

Conclusions

A high prevalence of syringe lending was observed among self-reported HIV-positive PWID in Bangkok, which was associated with high intensity drug use, polysubstance use, and frequently injecting with others. It is particularly concerning that individuals who lent syringes were more likely to be untreated for HIV disease given the known benefits of antiretroviral provision on the prevention of HIV transmission. These findings underscore the need to expand access to sterile syringes and HIV treatment among HIV-positive PWID in Thailand.

【 授权许可】

   
2015 Voon et al.

【 参考文献 】

• [1]World Health Organization. Injecting drug use. In: HIV/AIDS. World Health Organization. 2014. http://www.who.int/hiv/topics/idu/about/en/. Accessed 26 May 2014.
• [2]United Nations Office on Drugs and Crime (UNODC), The Joint United Nations Programme on HIV/AIDS (UNAIDS): WHO, UNODC, UNAIDS Technical Guide for Countries to set Targets for Universal Access to HIV Prevention, Treatment and care for injecting drug users. World Health Organization, Geneva; 2012.
• [3]Hayashi K, Ti L, Fairbairn N, Kaplan K, Suwannawong P, Wood E et al.. Drug-related harm among people who inject drugs in Thailand: summary findings from the Mitsampan Community Research Project. Harm Reduct J. 2013; 10:21. BioMed Central Full Text
• [4]Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP et al.. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010; 375:1014-28.
• [5]Kerr T, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Zhang R et al.. Expanding the reach of harm reduction in Thailand: experiences with a drug user-run drop-in centre. Int J Drug Policy. 2010; 21:255-8.
• [6]Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N et al.. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365:493-505.
• [7]Guidance on testing and counselling for HIV in settings attended by people who inject drugs: improving access to treatment, care and prevention. WHO, Geneva; 2009.
• [8]Ti L, Hayashi K, Kaplan K, Suwannawong P, Fu E, Wood E et al.. HIV testing and willingness to get HIV testing at a peer-run drop-in centre for people who inject drugs in Bangkok. Thailand BMC Public Health. 2012; 12:189. BioMed Central Full Text
• [9]Thailand AIDS response progress report. Reporting period: 2010‐2011. Joint United Nations Program on HIV/AIDS. 2012. 2012. Available at: http://www.unaids.org/sites/default/files/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_th_narrative_report.pdf. Accessed May 26, 2014.
• [10]Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K et al.. National expansion of antiretroviral treatment in Thailand, 2000–2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr. 2009; 50:506-12.
• [11]Kerr T, Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E. The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand. Int J Drug Policy. 2014; 25:171-4.
• [12]Voon P, Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E, et al. Factors associated with remaining untreated for HIV among injection drug users in Bangkok, Thailand [Oral presentation/Published abstract]. In: Proceedings of the 11th International Congress on AIDS in Asia and the Pacific. Bangkok, Thailand; 2013. 18–22 November.
• [13]Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010; 376:355-66.
• [14]Thai National AIDS Committee. Thailand Ending Aids: 2014 Thailand AIDS Response Progress Report. Report, Thai National AIDS Committee, 2014. http://www.unaids.org/sites/default/files/en/dataanalysis/knowyourresponse/countryprogressreports/2014countries/THA_narrative_report_2014.pdf (2014, accessed 16 July 2014).
• [15]Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH et al.. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg. 2006; 74:1111-6.
• [16]Maek ANW, Avihingsanon A, Ohata PJ. Challenges in providing treatment and care for viral hepatitis among individuals co-infected with HIV in resource-limited settings. AIDS Res Treat. 2012; 2012:948059.
• [17]Hayashi K, Wood E, Suwannawong P, Kaplan K, Qi J, Kerr T. Methamphetamine injection and syringe sharing among a community-recruited sample of injection drug users in Bangkok. Thailand Drug Alcohol Depend. 2011; 115:145-9.
• [18]Strathdee SA, Patrick DM, Archibald CP, Ofner M, Cornelisse PG, Rekart M et al.. Social determinants predict needle-sharing behaviour among injection drug users in Vancouver. Canada Addiction. 1997; 92:1339-47.
• [19]Hayashi K, Suwannawong P, Ti L, Kaplan K, Wood E, Kerr T. High rates of midazolam injection and associated harms in Bangkok. Thailand Addiction. 2013; 108:944-52.
• [20]Kerr T, Kiatying-Angsulee N, Fairbairn N, Hayashi K, Suwannawong P, Kaplan K et al.. High rates of midazolam injection among drug users in Bangkok. Thailand Harm Reduct J. 2010; 7:7. BioMed Central Full Text
• [21]Kerr T, Fairbairn N, Hayashi K, Suwannawong P, Kaplan K, Zhang R et al.. Difficulty accessing syringes and syringe borrowing among injection drug users in Bangkok. Thailand Drug Alcohol Rev. 2010; 29:157-61.
• [22]Ti L, Kerr T. The impact of harm reduction on HIV and illicit drug use. Harm Reduct J. 2014; 11:7. BioMed Central Full Text
• [23]Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV/AIDS. Drug situation in Vancouver. Vancouver: British Columbia Centre for Excellence in HIV/AIDS. 2013.
• [24]Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T et al.. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996; 348:987-91.
• [25]Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998; 51:253-63.
• [26]Weatherby NL, Needle R, Cesari H, Booth R, McCoy CB, Watters JK et al.. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Eval Program Plann. 1994; 17:347-55.
• [27]Metsch LR, Pereyra M, Purcell DW, Latkin CA, Malow R, Gomez CA et al.. Correlates of lending needles/syringes among HIV-seropositive injection drug users. J Acquir Immune Defic Syndr. 2007; 46 Suppl 2:S72-9.